U.S. stocks edged higher Wednesday morning, recovering slightly from this week’s selloff as Commerce Secretary Howard Lutnick ...

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

With U.S. stock markets set to open in two hours, Huntington Ingalls Industries Inc. (HII) was up 11.5% in pre-market trading, and Moderna Inc. (MRNA) was up 9.1%.

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...